4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000239
EVP, Chief Scientific Officer sold 20,536 shares at an average $84.95 ($1,744,623)
- EVP, Chief Scientific Officer acquired 15,000 shares (other)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-07 | Sale : show line 1 in the form 10b5-1 | −5,536 | $83.58 | $462,693 | 75,018 | D |
| 2026-07-07 | Other acquisition : show line 2 in the form 10b5-1 | +15,000 | 15,000 | I | ||
| 2026-07-07 | Sale : show line 3 in the form 10b5-1 | −15,000 | $85.46 | $1,281,930 | 0 | I |
| Open-market sales · 20,536 sh · avg $84.95 · $1,744,623 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-07 | Other disposition : show line 4 in the form 10b5-1 Restricted Stock Unit | −15,000 | 12,109 | D |
Loading xslF345X06/edgardoc.xml…